DXCM
DXCM
US · Stock · NYSE/NASDAQ
$71.54
Pre-Market · NYSE/NASDAQ
AIQ Score (0-100)
54
/100
NEUTRAL
Smart Score (1-10)
6 /10
Momentum45
Value37
Quality82
Risk47
Sentiment91

SignalIQ Stock Brief

Published · as of 2026-07-24

The most pronounced structural change observed is the sharp decrease in momentum over the past seven days (-31.0), indicating a significant loss of short-term buying pressure or trend adherence. Despite this, the high quality score (82.0) suggests that the company's underlying business fundamentals and operational health remain robust. The current timing score (35.0) is notably low, suggesting that market entry points may be suboptimal relative to historical averages. This combination of high intrinsic quality paired with poor immediate momentum and weak timing signals creates a structural tension: the asset possesses strong foundational characteristics but lacks immediate directional catalyst or optimal entry conditions. Risk remains elevated at 47.0, which aligns with the negative trend direction (-1.0) observed in the score vector. The signal metrics confirm this caution, showing an alpha of -23.23 and a negative Sharpe ratio of -0.35, reinforcing that recent returns have been poor relative to risk taken. A potential watch item is required: Monitor if the momentum delta reverses (delta > 10.0) while the quality score remains above 80.0; this would signal a confluence of renewed short-term interest and sustained fundamental strength.

Summary ▸

The significant decline in momentum (delta -31.0) suggests a rapid shift in short-term price action, while the quality score remains elevated at 82.0. This divergence implies that underlying fundamental strength is intact despite recent weakness in market timing and directional conviction.

Current market regime: Neutral

In a Neutral regime, DXCM's AIQ Score of 54/100 with Quality base of 82/100 and fading Momentum at 45/100 (Δ-31) signals mixed conviction. Wait for component alignment before adding exposure. Watch momentum trend for confirmation or fading.

Signal conflict detected

Valuation (37/100) is diverging from Momentum (45/100) and Sentiment (91/100) and Quality (82/100). DXCM's strong momentum and positive signals are running ahead of fundamental value — a setup that has historically required monitoring for mean reversion. Watch for RSI overbought signals as a confirmation trigger.

Why DXCM scores 54 — top signal drivers
Golden Cross Active
high-impact trend signal at 6.27% supporting upside conditions: Golden Cross Active.
bullish+76.00%
ATR Expansion - Breakout Mode
medium-impact volatility signal at 3.76% worth monitoring: ATR Expansion - Breakout Mode.
neutral+68.00%
EMA Ribbon Expansion Bullish
medium-impact trend signal at 0.475 supporting upside conditions: EMA Ribbon Expansion Bullish.
bullish+68.00%
MACD Bearish Crossover
low-impact momentum signal at 0.4748 warning of downside pressure: MACD Bearish Crossover.
bearish+61.00%
Healthcare·sector move·Market context unavailable.

Quick Stats

Market Cap
P/E Ratio
P/B Ratio
Dividend Yield
Beta
Volume
52W High
52W Low
Evidence Receipts + Persistence
AIQ score today
54/100
Neutral
30-day Avg AIQ
58/100
+4 vs today — trending down
Days with AIQ ≥ 60 (last 60)
30 of 60 trading days
Strongest driver
Sentiment 91/100 — top-tier
Binding constraint
Value 37/100 — weak
7-day momentum Δ
-31 pts — fading
AIQ Score Change Narrative

DXCM's 7-day signal profile is softening with AIQ change of -8.0 points and momentum delta of -31.0. Trend delta is -8.00, which helps frame whether the current move is accelerating or fading.

Snapshot: Sun, 26 Jul 2026 00:00:00 GMT. Baseline: 2026-07-17.

AIQ Δ7d: -8.0Momentum Δ7d: -31.0Value Δ7d: 0.0Quality Δ7d: 0.0Risk Δ7d: 0.0Trend Δ7d: -8.00
Weekly Score Historymethodology →
DateAIQMomValQualResilience
2026-07-255445378247
2026-07-186276378247
2026-07-116168378253
2026-07-045651378249
2026-06-275653378250
Recent News
See all news
Sentiment —
No recent news found for DXCM

DXCM (DXCM) Stock Analysis

Snapshot summary of AIQ score, trend, and risk context.

DXCM (DXCM) has an AIQ Score of 54/100 in a Neutral regime as of Jul 25, 2026. Sentiment is strongest at 91/100. Value is weakest at 37/100. The main conflict is that quality remains supportive at 82/100 while 7-day momentum is fading (-31.0 pts).

DXCM (DXCM) carries an AIQ Score of 54 out of 100, placing it in a mixed signal regime for this snapshot. A mid-range reading typically means component signals are not fully aligned, so interpretation should focus on what is improving versus what is lagging.

Beta is 1.53, implying roughly 53% higher sensitivity than a broad market baseline.

In the latest weekly profile, AIQ has moved -8.0 points over the last 7 days, momentum delta is -31.0, trend delta is -8.00, risk delta is 0.0. This combination is most useful for judging whether signal quality is strengthening or fading into mean reversion.

Evidence LayerPublic Evidence
Regime ContextDXCM is in a Neutral AIQ regime with score 54/100.
Signal ConflictThe primary conflict is that quality remains supportive at 82/100 while 7-day momentum is fading (-31.0 pts).
Factor EvidenceMomentum 45/100 · Value 37/100 · Quality 82/100 · Risk 47/100 · Sentiment 91/100
PersistenceDXCM has scored AIQ 60+ in 30 of the last 60 daily snapshots. 30-day avg: 58/100. 60-day avg: 59/100.
ChecklistStatusEvidence
Factor strengthPassSentiment is the strongest factor at 91/100.
TimingWaitMomentum is 45/100 with 7-day delta -31.0.
Regime fitWaitDXCM is in a Neutral regime at 54/100.
Risk controlWaitRisk factor is 47/100 with beta of 1.53 indicates above-market sensitivity.
ConflictWaitCurrent conflict: quality remains supportive at 82/100 while 7-day momentum is fading (-31.0 pts).
AIQ 60+ snapshots: 30/60
30-snapshot avg: 58/100
60-snapshot avg: 59/100
What Changed Recently (DXCM)

DXCM's 7-day signal profile is softening with AIQ change of -8.0 points and momentum delta of -31.0. Trend delta is -8.00, which helps frame whether the current move is accelerating or fading.

Signal snapshot as of Sun, 26 Jul 2026 00:00:00 GMT. 7-day comparison baseline: 2026-07-17.

AIQ Δ7d: -8.0
Momentum Δ7d: -31.0
Value Δ7d: 0.0
Quality Δ7d: 0.0
Risk Δ7d: 0.0
Trend Δ7d: -8.00
MetricCurrent
AIQ Score54/100
Price$71.54
Beta1.53

DXCM vs Medical Devices Peers

DXCM ranks 2 of 5 in this peer set. Full sector ranking →
Compare Stocks
SymbolAIQSmartVerdict
GMED557Neutral
DXCM546Neutral
ENOV547Neutral
GEHC515Neutral
EW453Neutral

Portfolio Implication

DXCM currently shows balanced but still concentration-sensitive risk. Beta is currently unavailable, so position sizing should be reviewed with scenario analysis.

DXCM Stock FAQ

What does the DXCM AIQ Score mean?

AIQ Score summarizes multiple factors for DXCM, including momentum, value, quality, and risk. Higher scores generally indicate stronger combined signals, but you should still validate with your own risk tolerance.

How often is DXCM data updated?

DXCM quote and scoring components refresh on the platform cadence. Always confirm timestamp freshness on-page before making time-sensitive decisions.

Should I compare DXCM with an index before investing?

Yes. Comparing DXCM versus benchmarks like SPY or QQQ helps you separate stock-specific strength from broader market moves.

Where can I review deeper DXCM fundamentals, technicals, and risk?

Use the Fundamentals, Technicals, and Risk tabs from this page to inspect driver-level metrics behind the headline score.

How the AIQ Score Is Built

Methodology, factor weights, and how to interpret score history

Read the methodology →

Loading DXCM...

© 2026 AlgoVestIQTermsPrivacyRisk Disclosure

Informational only, not investment advice. Investing involves risk, including loss of principal.